When Harry Travis first met Neil Euliano and learned about his medication adherence technology, the pharmaceutical industry was beginning to usher in the age of pricey drugs with Hepatitis C therapies that hit the market at prices like $500 or $1,000 dollars a pill. “It just so happened at the time, really expensive medications were […]
Cardinal Health
Cardinal Health, Hamilton Medical, Zoll Medical score DoD contracts
Cardinal Health (NYSE: CAH) will receive $29.2 million under a new U.S. Department of Defense contract, with Hamilton Medical and Zoll Medical also securing contracts in the tens of millions of dollars. Cardinal Health’s contract win, announced Sept. 29, comes nearly eight months after Dublin, Ohio–based Cardinal Health secured a $2.25 billion surgical supplies contract […]
Cardinal Health inks distro deal with Avadim Tech
Life science company Avadim Technologies said yesterday it inked a deal withCardinal Health (NYSE:CAH) to distribute Avadim’s Theraworx topical bionome therapies designed to prevent catheter-associated urinary tract infections and complications. The companies said that the Theraworx topical solution will compliment Cardinal Health’s Dover urological portfolio. “We are honored to partner with one of the most influential […]
The 10 largest medtech employers – and what their workers really think
Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the largest […]
Cardinal Health shares drop on Q4, FY2017 earnings release
Shares in Cardinal Health (NYSE:CAH) fell today after the medical device maker posted a 17.7% drop in profits in its 4th quarter and 9.6% drop for its fiscal year 2017 earnings results, despite topping expectations on Wall Street. The Dublin, Ohio-based company posted profits of $274 million, or 86¢ per share, on sales of $33 billion […]
Cardinal Health closes $6B buy of Medtronic patient care, DVT and nutritional insufficiency biz
Cardinal Health (NYSE:CAH) said today it closed its $6.1 billion acquisition of Medtronic‘s (NYSE:MDT) patient care, deep vein thrombosis and nutritional insufficiency business. Dublin, Ohio-based Cardinal Health said that the acquisition was funded through a combined $4.5 billion in new senior unsecured notes alongside existing cash and borrowings from credit facilities. The deal includes a total […]
Report: Cardinal Health puts Chinese drug distro biz on the auction block
Cardinal Health (NYSE:CAH) is reportedly shopping its Chinese drug distribution business, drawing keen interest from state-backed pharmaceutical firms in a deal that could be worth as much as $1.5 billion. Citing “sources familiar with the matter,” Reuters reported that Shanghai Pharmaceutical, China Resources Pharmaceutical Group and Sinopharm Group are among the potential bidders for Cardinal Health China, […]
Medtech M&A: The 10 biggest deals so far in 2017
Over the past several years, the healthcare industry as a whole has experienced an abundance of mergers and acquisitions – major players are buying up their peers in deals ranging from millions to billions. The trend is continuing, and the healthcare playing field continues to be shaped by these mega-transactions. For the medical device industry, […]
Here are the top 5 medtech stories of mid-2017
The middle of 2017 is shaping up to be a continued whirlwind of activity for medtech. FDA is getting used to its new leadership but is facing a continued lack of clarity on user fees and UDIs. Industry is seeing a deeper consolidation in medical supplies, exemplified in Cardinal Health’s purchase of patient recovery supplies from […]
Cardinal Health’s fiscal Q3 earnings top forecast, but sales miss the mark
Fiscal 3rd-quarter earnings for Cardinal Health (NYSE:CAH) came in ahead of the consensus estimate on Wall Street, but the top line missed expectations by nearly $500 million. The Dublin, Ohio-based company posted profits of $381 million, or $1.20 per share, on sales of $31.82 billion for the 3 months ended March 31, for a bottom-line slide […]
UPDATE: Medtronic deals patient monitoring & recovery biz to Cardinal Health for $6B
Medtronic (NYSE:MDT) said today that it agreed to deal a portion of its patient monitoring & recovery business to Cardinal Health (NYSE:CAH) for $6.1 billion in cash, confirming months of speculation that the world’s largest medical device maker was looking to slim down. Rumors that the Fridley, Minn.-based company wanted to divest the supplies business, gained […]